Princess Diana’s style is nothing short of legendary and so was her jewelry. Read ahead for the surprising history behind 10 ...

SAPPHIRE enrolled 156 patients aged 2-12 years ... historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients.

Scholar Rock (SRRK) announced that new efficacy and safety data from the Phase 3 pivotal SAPPHIRE trial will be presented in multiple clinical presentations at the 2025 Muscular Dystrophy ...

SAPPHIRE enrolled 156 patients aged 2-12 years ... Additional details can be found here. About Scholar Rock Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers ...

Fogel, Ph.D., Director of Discovery Biology at Scholar Rock. “We look forward to the data from our positive Phase 3 SAPPHIRE trial of apitegromab in patients with spinal muscular atrophy being ...